137 related articles for article (PubMed ID: 34553657)
1. Follow-up outcomes of different bypass surgical modalities for adults with ischaemic-type moyamoya disease.
Gao P; Chen D; Yuan S; Kong T; Zhang D; Zhu X; Li X; Zhen Y; Yan D
Br J Neurosurg; 2023 Apr; 37(2):148-157. PubMed ID: 34553657
[TBL] [Abstract][Full Text] [Related]
2. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
[TBL] [Abstract][Full Text] [Related]
3. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study.
Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Ye X; Liu X; Zhang Q; Wang J; Yang Z; Zhao M; Zhao J
J Neurosurg; 2018 May; 128(5):1327-1337. PubMed ID: 28686113
[TBL] [Abstract][Full Text] [Related]
4. Postoperative neovascularization, cerebral hemodynamics, and clinical prognosis between combined and indirect bypass revascularization procedures in hemorrhagic moyamoya disease.
Sun J; Li ZY; Chen C; Ling C; Li H; Wang H
Clin Neurol Neurosurg; 2021 Sep; 208():106869. PubMed ID: 34419781
[TBL] [Abstract][Full Text] [Related]
5. Early Surgery for Moyamoya Is Not Associated with Worse Outcomes: Analysis of a North American Adult Cohort.
Reed LK; Soto JM; Benardete EA
World Neurosurg; 2023 Jun; 174():e53-e61. PubMed ID: 36871651
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
7. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Li H; Wang R; Zhang Y; Zhang D; Zhao J
World Neurosurg; 2017 Jul; 103():283-290. PubMed ID: 28366750
[TBL] [Abstract][Full Text] [Related]
9. Time Course of Neoangiogenesis After Indirect Bypass Surgery for Moyamoya Disease : Comparison of Short-term and Long-term Follow-up Angiography.
Zhao Y; Lu J; Zhang Q; Zhang Y; Zhang D; Wang R; Zhao Y
Clin Neuroradiol; 2020 Mar; 30(1):91-99. PubMed ID: 30511151
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Long-Term Effect Between Direct and Indirect Bypass for Pediatric Ischemic-Type Moyamoya Disease: A Propensity Score-Matched Study.
Zhao Y; Lu J; Yu S; Li J; Deng X; Zhang Y; Zhang D; Wang R; Wang H; Zhao Y
Front Neurol; 2019; 10():795. PubMed ID: 31417483
[No Abstract] [Full Text] [Related]
11. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
[TBL] [Abstract][Full Text] [Related]
12. Surgical revascularizations for pediatric moyamoya: a systematic review, meta-analysis, and meta-regression analysis.
Lee KS; Zhang JJY; Bhate S; Ganesan V; Thompson D; James G; Silva AHD
Childs Nerv Syst; 2023 May; 39(5):1225-1243. PubMed ID: 36752913
[TBL] [Abstract][Full Text] [Related]
13. Angiographic and clinical outcomes of non-patent anastomosis after bypass surgery in adult moyamoya disease.
Kim SH; Lee H; Yoo M; Jin S; Lee S; Choi BS; Kim HY; Jin SC
Acta Neurochir (Wien); 2019 Feb; 161(2):379-384. PubMed ID: 30604067
[TBL] [Abstract][Full Text] [Related]
14. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
J Neurosurg; 2019 Feb; 132(2):421-433. PubMed ID: 30771781
[TBL] [Abstract][Full Text] [Related]
15. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality.
Lee SB; Kim DS; Huh PW; Yoo DS; Lee TG; Cho KS
Acta Neurochir (Wien); 2012 Jul; 154(7):1179-87. PubMed ID: 22476796
[TBL] [Abstract][Full Text] [Related]
18. Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.
Bot GM; Burkhardt JK; Gupta N; Lawton MT
J Neurosurg Pediatr; 2018 Nov; 23(2):198-203. PubMed ID: 30497164
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults.
Jeon JP; Kim JE; Cho WS; Bang JS; Son YJ; Oh CW
J Neurosurg; 2018 Mar; 128(3):793-799. PubMed ID: 28474994
[TBL] [Abstract][Full Text] [Related]
20. Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease.
Uchino H; Kazumata K; Ito M; Nakayama N; Kuroda S; Houkin K
Neurosurg Rev; 2021 Feb; 44(1):599-605. PubMed ID: 32076897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
